What's this? This is an unbiased just-the-facts news summary about Ebola, Federal Food & Drug Administration, Kevin Whaley, LeafBio, Mapp and ZMapp. To see the full newsline, click the red tabs below or Learn more

18 Sep, 2015

Fast tracked

Announcement0 Comments

ZMapp is granted fast track approval in America. LeafBio says the grant is an “important milestone” which brings them closer to eventually gaining approval. The drug has been administered under emergency use authorization to nine infected patients in Africa in addition to two infected missionaries in Europe during its first clinical trial. LeafBio CEO Whaley:

We are gratified to receive this designation for ZMapp. We are hopeful that this step will accelerate its access once safety and efficacy are demonstrated to satisfaction by FDA in ongoing clinical trials.

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments